Windtree Therapeutics, Inc. (WINT)
0.0003
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Windtree Therapeutics Net Income (Quarterly) : -28.08M for Sept. 30, 2025
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | -28.08M |
| June 30, 2025 | -10.64M |
| March 31, 2025 | -4.045M |
| December 31, 2024 | 2.767M |
| September 30, 2024 | -2.749M |
| June 30, 2024 | -12.02M |
| March 31, 2024 | 10.22M |
| December 31, 2023 | -5.154M |
| September 30, 2023 | -4.425M |
| June 30, 2023 | -6.601M |
| March 31, 2023 | -4.111M |
| December 31, 2022 | -9.692M |
| September 30, 2022 | -4.056M |
| June 30, 2022 | -17.33M |
| March 31, 2022 | -8.127M |
| December 31, 2021 | -13.07M |
| September 30, 2021 | -8.213M |
| June 30, 2021 | -37.39M |
| March 31, 2021 | -8.961M |
| December 31, 2020 | -7.454M |
| September 30, 2020 | -9.02M |
| June 30, 2020 | -9.558M |
| March 31, 2020 | -6.534M |
| December 31, 2019 | -7.375M |
| September 30, 2019 | -7.126M |
| Date | Value |
|---|---|
| June 30, 2019 | -6.437M |
| March 31, 2019 | -6.537M |
| December 31, 2018 | -21.55M |
| September 30, 2018 | -3.927M |
| June 30, 2018 | -3.052M |
| March 31, 2018 | -4.512M |
| December 31, 2017 | 2.473M |
| September 30, 2017 | -5.443M |
| June 30, 2017 | -6.752M |
| March 31, 2017 | -8.724M |
| December 31, 2016 | -6.602M |
| September 30, 2016 | -8.363M |
| June 30, 2016 | -10.62M |
| March 31, 2016 | -13.90M |
| December 31, 2015 | -10.11M |
| September 30, 2015 | -21.56M |
| June 30, 2015 | -11.33M |
| March 31, 2015 | -12.18M |
| December 31, 2014 | -10.64M |
| September 30, 2014 | -11.32M |
| June 30, 2014 | -10.62M |
| March 31, 2014 | -11.48M |
| December 31, 2013 | -11.73M |
| September 30, 2013 | -12.22M |
| June 30, 2013 | -8.627M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 28.08M |
| EPS Diluted (Quarterly) | -1.085 |